Air Liquide (OTCMKTS:AIQUY) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Air Liquide (OTCMKTS:AIQUY) from a strong sell rating to a hold rating in a research note issued to investors on Wednesday,Zacks.com reports.

A number of other research analysts have also commented on the company. Citigroup reiterated a “buy” rating on shares of Air Liquide in a report on Wednesday. Kepler Capital Markets upgraded shares of Air Liquide from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 31st. Finally, Morgan Stanley upgraded shares of Air Liquide from an “underweight” rating to an “overweight” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

Air Liquide Stock Performance

OTCMKTS AIQUY opened at $39.60 on Wednesday. Air Liquide has a twelve month low of $32.88 and a twelve month high of $41.24. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.14 and a quick ratio of 0.90. The stock has a 50-day simple moving average of $40.07 and a 200 day simple moving average of $40.28.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Air Liquide stock. GAMMA Investing LLC raised its stake in shares of Air Liquide (OTCMKTS:AIQUY) by 25.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,977 shares of the basic materials company’s stock after purchasing an additional 2,259 shares during the quarter. GAMMA Investing LLC’s holdings in Air Liquide were worth $433,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 0.03% of the company’s stock.

Air Liquide Company Profile

Air Liquide is a Paris‑headquartered multinational that develops, manufactures and supplies industrial and medical gases, related equipment and services. Founded in 1902, the company has grown into a major global supplier of gases such as oxygen, nitrogen, argon, hydrogen and a wide range of specialty gases used across industrial, healthcare and research applications.

Its core activities include on‑site gas production, bulk and packaged gas distribution (cylinders and cryogenic deliveries), installation and maintenance of gas handling and storage equipment, and engineering for large industrial gas projects.